Company Overview
Avalon GloboCare Corp. operates within the Real Estate sector, specifically classified under the Real Estate Services industry, where it owns and operates commercial real estate properties in the United States. In addition to its property holdings, the company distributes the KetoAir device, a breathalyzer system designed to detect acetone levels in exhaled breath, and utilizes the AI Nutritionist software program to assist with nutritional management. The entity is a small-scale operation with a total workforce of 4 employees, reflecting a lean operational structure typical of niche real estate and technology distribution firms. The company currently holds a market capitalization of $3.39M and reported trailing twelve-month revenue of $1.61M, indicating a micro-cap status that suggests limited market liquidity and a specialized business focus rather than broad diversification. These valuation metrics place the company in a lower tier of the market, where capital allocation decisions are heavily influenced by specific asset performance and the success of its ancillary technology distribution efforts rather than scale economies.
Financial Health
The company generated revenue of $1.61M over the trailing twelve-month period, yet recorded a net income of $-18,757,160, revealing a severe disconnect between top-line sales and bottom-line profitability that points to substantial operating expenses or non-operating losses. EBITDA stands at $-6,903,727, further confirming that the core operations are cash-flow negative before interest, taxes, depreciation, and amortization. Free cash flow is reported at $-2,781,598, which signifies that the company is consuming cash reserves to fund operations and asset maintenance rather than generating surplus capital for reinvestment or debt reduction. Profitability is further eroded by a gross margin of 35.7%, an operating margin of -21.8%, and a profit margin of 0.0%, illustrating that while the cost of goods sold is controlled, overhead costs and other expenses are consuming a significant portion of revenue. The balance sheet shows a cash position of $333,931 against total debt of $7.25M, resulting in a debt-to-equity ratio of N/A due to the negative equity position, which indicates a highly leveraged and distressed financial structure. Liquidity constraints are severe, as evidenced by a current ratio of 0.15, meaning the company possesses only 15 cents in current assets for every dollar of current liabilities, raising concerns about its ability to meet short-term obligations without refinancing or asset liquidation. Return on Equity is calculated at -4129.8% and Return on Assets at -30.9%, metrics that demonstrate the complete erosion of shareholder value and the inefficient use of total assets to generate profit.
Valuation Assessment
Trailing P/E and forward P/E ratios are both listed as N/A due to the company's consistent net losses, which prevents the calculation of a traditional earnings multiple and implies that earnings-based valuation models are currently inapplicable. The price-to-book ratio is -0.12, a negative figure that indicates the market values the company's equity significantly below its book value, often reflecting market skepticism regarding the recoverability of assets or the severity of accumulated losses. Alternative valuation metrics such as the price-to-sales ratio of 2.10 and an EV/EBITDA of -3.14 suggest that investors are pricing the stock based on revenue potential and enterprise value multiples rather than current profitability, a common practice for distressed or turnaround real estate plays. The stock has exhibited significant volatility over the last year, trading between a 52-week high of $6.10 and a 52-week low of $0.42, highlighting the extreme price sensitivity typical of small-cap real estate and technology distribution stocks. The beta of -0.22 is a negative value, which technically implies an inverse correlation to the broader market, though in practice for such a small cap, it reflects extreme idiosyncratic risk and instability rather than a systematic hedge.
Growth & Income
Revenue growth and earnings growth rates are both N/A, as the company has not demonstrated positive year-over-year expansion in the available financial data, suggesting a stagnant or contracting business environment. The company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which means all available earnings are theoretically reinvested into operations, though the negative net income limits the ability to fund meaningful growth initiatives. The absence of a dividend yield confirms that the firm prioritizes capital retention over income distribution, a strategy often seen in companies attempting to service high debt loads or rebuild cash reserves. The overall growth and income profile is characterized by a lack of historical earnings expansion and an inability to return capital to shareholders via dividends, positioning the asset as a pure play on potential future operational turnaround rather than a current income generator.